<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00995748</url>
  </required_header>
  <id_info>
    <org_study_id>DIREG_R_04434</org_study_id>
    <nct_id>NCT00995748</nct_id>
  </id_info>
  <brief_title>The RECORD Asia-Pacific Atrial Fibrillation Registry</brief_title>
  <acronym>RECORDAF-AP</acronym>
  <official_title>REgistry on Cardiac Rhythm disORDers in Asia-Pacific</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF)
      over one year in patients attending clinical or specialized practices.

      The Secondary objectives are:

        -  To describe key demographics and treatment features in AF patients visiting
           cardiologists in various countries in Asia-Pacific.

        -  To establish correlation between control of AF and clinical outcomes.

        -  To establish correlation between treatment strategies and AF control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of therapeutic success by patients in sinus rhythm or heart rate control at target (&lt; 80 beats per minute at rest)</measure>
    <time_frame>At 12 ± 3 months follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of clinical outcomes (Cardiovascular death, Stroke, Myocardial infarction, etc) for patients in rhythm versus rate control strategies</measure>
    <time_frame>At 12 ± 3 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment effectiveness evaluated by the proportion of patients in sinus rhythm</measure>
    <time_frame>At 1 year follow-up</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">2674</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from office or hospital-based cardiologists from Asia-Pacific countries
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient presenting with either:

               -  History of atrial fibrillation diagnosed &lt; 1 year by standard Electro-Cardiogram
                  (ECG) or by ECG-Holter monitoring (treated or not or whatever rhythm at
                  inclusion).

               -  New atrial fibrillation diagnosed by standard ECG or by ECG-Holter monitoring at
                  inclusion visit.

          -  Patient eligible for a pharmacological treatment of AF (by rhythm or rate control
             agent).

        Exclusion Criteria:

          -  AF due to transient cause (thyrotoxicosis, alcohol intoxication, acute phase of
             myocardial infarction, pericarditis, myocarditis, electrocution, pulmonary embolism or
             other pulmonary disease, hydroelectrolytic disorder, metabolic disorder, etc.).

          -  Post cardiac surgery AF (≤3 months).

          -  Mentally disabled patients unable to understand or sign the written informed consent.

          -  Patients unable to comply with follow-up visits.

          -  Patients with pacemaker, Implantable Cardioverter Defibrillator (ICD).

          -  Patients scheduled for pulmonary vein ablation, AV node/His bundle ablation, or
             pacemaker implantation.

          -  Patient included in any clinical trial in the previous 3 months.

          -  Pregnant or breastfeeding women.

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Sciences &amp; Operations</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Macquarie Park</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Makati City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>China</country>
    <country>Hong Kong</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Philippines</country>
    <country>Taiwan</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2009</study_first_submitted>
  <study_first_submitted_qc>October 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2009</study_first_posted>
  <last_update_submitted>February 16, 2012</last_update_submitted>
  <last_update_submitted_qc>February 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

